With HuD shRNA treatment, all HuD high expresser neuroblastoma and small cell lung carcinoma cells had significant losses in viability/proliferation and not in low HuD-expresser SK-N-MC (Fig. 1J). This evidence concerns the gene ELAVL4 and neuroblastoma.